Lower urinary tract effects of ureteral stent length and intravesical position.


Journal

Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169

Informations de publication

Date de publication:
31 Aug 2023
Historique:
accepted: 22 08 2023
medline: 4 9 2023
pubmed: 1 9 2023
entrez: 31 8 2023
Statut: epublish

Résumé

Ureteral stents can cause lower urinary tract problems such as stent-related irritative symptoms and urinary tract infections. This study aimed to determine the lower urinary tract effects of ureteral stent length and intravesical position in children. Patients who underwent double-J stenting after urological procedures between January 2017 and January 2022 were included in the study. The patients were assessed in terms of age, irritative symptoms, urinary tract infections, and stent length. The intravesical position of the ureteral stents was grouped as cross-trigonal and ipsilateral. The distribution of irritative symptoms, frequency of urinary tract infections and stent length were analyzed according to intravesical location. A total of 47 patients were included in the study. The median age was 5 years (range: 1-16). Cross-trigonal stent position was significantly associated with symptoms of urgency (p = 0.046), suprapubic pain (p = 0.002), and lower mean age (p = 0.004). Urinary tract infections were more frequent in patients whose placed stents were longer than recommended (p < 0.001) or were in cross-trigonal position (p = 0.043). Our results suggest that stent-related irritative symptoms and urinary tract infections can be reduced in pediatric patients using a suitably sized ureteral stent and considering its intravesical position.

Identifiants

pubmed: 37653165
doi: 10.1007/s00383-023-05542-7
pii: 10.1007/s00383-023-05542-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

258

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Zhu H, Wang J, Deng Y et al (2020) Use of double-J ureteric stents post-laparoscopic pyeloplasty to treat ureteropelvic junction obstruction in hydronephrosis for pediatric patients: a single-center experience. J Int Med Res 48:300060520918781. https://doi.org/10.1177/0300060520918781
doi: 10.1177/0300060520918781 pubmed: 32345075
Thomas F, Rasguido A, Barusso G, Hernández R, Sanguinetti H, Caruso D, Autrán-Gómez AM, García-Perdomo HA (2021) Preoperative double J stent placement in the endoscopic treatment of ureteral and renal stone: a multicenter, national study. Arch Esp Urol 74:389–396
pubmed: 33942730
Kawahara T, Ito H, Terao H, Ogawa T, Uemura H, Kubota Y, Matsuzaki J (2012) Changing to a loop-type ureteral stent decreases patients’ stent-related symptoms. Urol Res 40:763–767. https://doi.org/10.1007/s00240-012-0500-4
doi: 10.1007/s00240-012-0500-4 pubmed: 22899382
Miyaoka R, Monga M (2009) Ureteral stent discomfort: etiology and management. Indian J Urol 25:455–460. https://doi.org/10.4103/0970-1591.57910
doi: 10.4103/0970-1591.57910 pubmed: 19955667 pmcid: 2808646
Zumstein V, Betschart P, Albrich WC, Buhmann MT, Ren Q, Schmid HP, Abt D (2017) Biofilm formation on ureteral stents—ıncidence, clinical impact, and prevention. Swiss Med Wkly 147:w14408. https://doi.org/10.4414/smw.2017.14408
doi: 10.4414/smw.2017.14408 pubmed: 28165539
Farhat W, Bägli DJ, Capolicchio G, O’Reilly S, Merguerian PA, Khoury A, McLorie GA (2000) The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol 164:1011–1015. https://doi.org/10.1097/00005392-200009020-00023
doi: 10.1097/00005392-200009020-00023 pubmed: 10958730
Oh JJ, Lee S, Cho SY, Lee SW, Cho MC, Na W, Park JH, Lee SB, Ahh S, Jeong CW (2017) Effects of naftopidil on double-J stent-related discomfort: a multicenter, randomized, double-blinded, placebo-controlled study. Sci Rep 7:4154. https://doi.org/10.1038/s41598-017-04505-y
doi: 10.1038/s41598-017-04505-y pubmed: 28646216 pmcid: 5482907
Betschart P, Piller A, Zumstein V, Schmid HP, Engeler DS, Güsewell S, Pratsinis M, Abt D (2021) Reduction of stent-associated morbidity by minimizing stent material: a prospective, randomized, single-blind superiority trial assessing a customized ‘suture stent.’ BJU Int 127:596–605. https://doi.org/10.1111/bju.15290
doi: 10.1111/bju.15290 pubmed: 33152169
Shah J, Kulkarni RP (2005) Height does not predict ureteric length. Clin Radiol 60:812–814. https://doi.org/10.1016/j.crad.2004.08.018
doi: 10.1016/j.crad.2004.08.018 pubmed: 15978893
Palmer JS, Palmer LS (2007) Determining the proper stent length to use in children: age plus 10. J Urol 178:1566–1569. https://doi.org/10.1016/j.juro.2007.03.191
doi: 10.1016/j.juro.2007.03.191 pubmed: 17707050
Pilcher JM, Patel U (2002) Choosing the correct length of ureteric stent: a formula based on the patient’s height compared with direct ureteric measurement. Clin Radiol 57:59–62. https://doi.org/10.1053/crad.2001.0737
doi: 10.1053/crad.2001.0737 pubmed: 11798204
Lingeman JE, Preminger GM, Goldfischer ER, Krambeck AE (2009) Assessing the impact of ureteral stent design on patient comfort. J Urol 181:2581–2587. https://doi.org/10.1016/j.juro.2009.02.019
doi: 10.1016/j.juro.2009.02.019 pubmed: 19375088 pmcid: 3164810
Damiano R, Autorino R, De Sio M, Cantiello F, Quarto G, Perdona S, Sacco R, D’Armiento M (2005) Does the size of ureteral stent impact urinary symptoms and quality of life? A prospective randomized study. Eur Urol 48:673–678. https://doi.org/10.1016/j.eururo.2005.06.006
doi: 10.1016/j.eururo.2005.06.006 pubmed: 16039775
Joshi HB, Okeke A, Newns N, Keeley FX, Timoney AG (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology 59:511e6. https://doi.org/10.1016/s0090-4295(01)01644-2e
doi: 10.1016/s0090-4295(01)01644-2e
Lingeman JE, Preminger GM, Berger Y, Denstedt JD, Goldstone L, Segura JW, Auge BK, Watterson JD, Kuo RL (2003) Use of a temporary ureteral drainage stent after uncomplicated ureteroscopy: results from a phase II clinical trial. J Urol 169:1682–1688. https://doi.org/10.1097/01.ju.0000055600.18515.a1
doi: 10.1097/01.ju.0000055600.18515.a1 pubmed: 12686808
Loh-Doyle JC, Low RK, Monga M, Nguyen MM (2015) Patient experiences and preferences with ureteral stent removal. J Endourol 29:35–40. https://doi.org/10.1089/end.2014.0402
doi: 10.1089/end.2014.0402 pubmed: 25019375 pmcid: 4287107
Taylor WN, McDougall IT (2002) Minimally invasive ureteral stent retrieval. J Urol 168:2020–2023. https://doi.org/10.1016/S0022-5347(05)64286-3
doi: 10.1016/S0022-5347(05)64286-3 pubmed: 12394699
Rassweiler MC, Michel MS, Ritter M, Honeck P (2017) Magnetic ureteral stent removal without cystoscopy: a randomized controlled trial. J Endourol 31:762–766. https://doi.org/10.1089/end.2017.0051
doi: 10.1089/end.2017.0051 pubmed: 28478732
Moltzahn F, Haeni K, Birkhäuser FD, Roth B, Thalmann GN, Zehnder P (2013) Peri-interventional antibiotic prophylaxis only vs continuous low-dose antibiotic treatment in patients with JJ stents: a prospective randomised trial analysing the effect on urinary tract infections and stent-related symptoms. BJU Int 111:289–295. https://doi.org/10.1111/j.1464-410X.2012.11592.x
doi: 10.1111/j.1464-410X.2012.11592.x pubmed: 23253774
Sundén F, Håkansson L, Ljunggren E, Wullt B (2010) Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol 184:179–185. https://doi.org/10.1016/j.juro.2010.03.024
doi: 10.1016/j.juro.2010.03.024 pubmed: 20483149
Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA (2004) Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 18:891–896. https://doi.org/10.1089/end.2004.18.891
doi: 10.1089/end.2004.18.891 pubmed: 15659928
Al-Kandari AM, Al-Shaiji TF, Shaaban H, Ibrahim HM, Elshebiny YH, Shokeir AA (2007) Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol 21:698–702. https://doi.org/10.1089/end.2007.9949
doi: 10.1089/end.2007.9949 pubmed: 17705753
Liu X, Huang C, Guo Y, Yue Y, Hong J (2019) Comparison of DJ stented, external stented and stent-less procedures for pediatric pyeloplasty: a network meta-analysis. Int J Surg 68:126–133. https://doi.org/10.1016/j.ijsu.2019.07.001
doi: 10.1016/j.ijsu.2019.07.001 pubmed: 31279854
Chalhoub M, Kohaut J, Vinit N, Botto N, Aigrain Y, Héloury Y, Lottmann H, Blanc T (2021) Feasibility and safety of magnetic-end double-J ureteral stent insertion and removal in children. World J Urol 39:1649–1655. https://doi.org/10.1007/s00345-020-03339-0
doi: 10.1007/s00345-020-03339-0 pubmed: 32623499
Hruby GW, Ames CD, Yan Y, Monga M, Landman J (2007) Correlation of ureteric length with anthropometric variables of surface body habitus. BJU Int 99:1119–1122. https://doi.org/10.1111/j.1464-410X.2007.06757.x
doi: 10.1111/j.1464-410X.2007.06757.x pubmed: 17309553
Martinez-Garcia R, Ubeda-Sansano MI, Ez-Domingo J, Perez-Hoyos S, Gil-Salom M (2014) It is time to abandon “Expected bladder capacity”. systematic review and newmodels for children’s normal maximum voided volumes. Neurourol Urodyn 33:1092–1098. https://doi.org/10.1002/nau.22452
doi: 10.1002/nau.22452 pubmed: 23847007
Finney RP (1978) Experience with new double J-ureteral catheter stent. J Urol 120:678–681. https://doi.org/10.1016/s0022-5347(17)57326-7
doi: 10.1016/s0022-5347(17)57326-7 pubmed: 731804
Dunn MD, Portis AJ, Kahn SA, Yan Y, Shalhav AL, Elbahnasy AM, Bercowsky E, Hoenig DM, Wolf JS Jr, McDougall EM, Clayman RV (2000) Clinical effectiveness of new stent design: randomized single-blind comparison of tail and double-pigtail stents. J Endourol 14:195–202. https://doi.org/10.1089/end.2000.14.195
doi: 10.1089/end.2000.14.195 pubmed: 10772515
Kawahara T, Sakamaki K, Ito H, Kuroda S, Terao H, Makiyama K, Uemura H, Yao M, Miyamoto H, Matsuzaki J (2016) Developing a preoperative predictive model for ureteral length for ureteral stent insertion. BMC Urol 16:70. https://doi.org/10.1186/s12894-016-0189-8
doi: 10.1186/s12894-016-0189-8 pubmed: 27903253 pmcid: 5131421

Auteurs

Caner Isbir (C)

Faculty of Medicine, Department of Pediatric Surgery, Mersin University, Mersin, Turkey. caner.isbir@gmail.com.

Şener Çolak (Ş)

Faculty of Medicine, Department of Pediatric Surgery, Mersin University, Mersin, Turkey.

Lara Taşan (L)

Faculty of Medicine, Department of Pediatric Surgery, Mersin University, Mersin, Turkey.

Hakan Taşkınlar (H)

Faculty of Medicine, Department of Pediatric Surgery, Mersin University, Mersin, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH